Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: A systematic review

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|25|5|872-879

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.25, Iss.5, 2010-05, pp. : 872-879

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis B virus quasispecies evolution after liver transplantation in patients under long‐term lamivudine prophylaxis with or without hepatitis B immune globulin

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 2, 2015-04 ,pp. : 208-220

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 18, Iss. 5, 2016-10 ,pp. : 667-673

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors for hepatitis B virus recurrence after living donor liver transplantation: A 17‐year experience at a single center

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 12, 2015-12 ,pp. : 1203-1210

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lamivudine Therapy for Decompensated Liver Cirrhosis Related to Hepatitis B Virus Infection

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 388-393

Karger

Access to resources Recommend Favorite

Occult hepatitis B virus infection predicts de novo hepatitis B infection in patients with alcoholic cirrhosis after liver transplantation

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 897-904

John Wiley & Sons Inc

Access to resources Recommend Favorite